TY - JOUR
T1 - IRAK-4 mutation (Q293X)
T2 - Rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells
AU - Davidson, Donald J.
AU - Currie, Andrew J.
AU - Bowdish, Dawn M.E.
AU - Brown, Kelly L.
AU - Rosenberger, Carrie M.
AU - Ma, Rebecca C.
AU - Bylund, Johan
AU - Campsall, Paul A.
AU - Puel, Anne
AU - Picard, Capucine
AU - Casanova, Jean Laurent
AU - Turvey, Stuart E.
AU - Hancock, Robert E.W.
AU - Devon, Rebecca S.
AU - Speert, David P.
PY - 2006/12/1
Y1 - 2006/12/1
N2 - Innate immunodeficiency has recently been reported as resulting from the Q293X IRAK-4 mutation with consequent defective TLR/IL-1R signaling. In this study we report a method for the rapid allele-specific detection of this mutation and demonstrate both cell type specificity and ligand specificity in defective IL-1R-associated kinase (IRAK)-4-deficient cellular responses, indicating differential roles for this protein in human PBMCs and primary dermal fibroblasts and in LPS, IL-1β, and TNF-α signaling. We demonstrate transcriptional and post-transcriptional defects despite NF-κB signaling and intact MyD88-independent signaling and propose that dysfunctional complex 1 (IRAK1/TRAF6/TAK1) signaling, as a consequence of IRAK-4 deficiency, generates specific defects in MAPK activation that could underpin this patient's innate immunodeficiency. These studies demonstrate the importance of studying primary human cells bearing a clinically relevant mutation; they underscore the complexity of innate immune signaling and illuminate novel roles for IRAK-4 and the fundamental importance of accessory proinflammatory signaling to normal human innate immune responses and immunodeficiencies.
AB - Innate immunodeficiency has recently been reported as resulting from the Q293X IRAK-4 mutation with consequent defective TLR/IL-1R signaling. In this study we report a method for the rapid allele-specific detection of this mutation and demonstrate both cell type specificity and ligand specificity in defective IL-1R-associated kinase (IRAK)-4-deficient cellular responses, indicating differential roles for this protein in human PBMCs and primary dermal fibroblasts and in LPS, IL-1β, and TNF-α signaling. We demonstrate transcriptional and post-transcriptional defects despite NF-κB signaling and intact MyD88-independent signaling and propose that dysfunctional complex 1 (IRAK1/TRAF6/TAK1) signaling, as a consequence of IRAK-4 deficiency, generates specific defects in MAPK activation that could underpin this patient's innate immunodeficiency. These studies demonstrate the importance of studying primary human cells bearing a clinically relevant mutation; they underscore the complexity of innate immune signaling and illuminate novel roles for IRAK-4 and the fundamental importance of accessory proinflammatory signaling to normal human innate immune responses and immunodeficiencies.
UR - http://www.scopus.com/inward/record.url?scp=33751580085&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.177.11.8202
DO - 10.4049/jimmunol.177.11.8202
M3 - Article
C2 - 17114497
AN - SCOPUS:33751580085
VL - 177
SP - 8202
EP - 8211
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 11
ER -